Larson Financial Group’s Zenas BioPharma ZBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.7K Buy
545
+91
+20% +$2.8K ﹤0.01% 2296
2026
Q2
$11.5K Buy
454
+161
+55% +$3.2K ﹤0.01% 2317
2026
Q1
$5.73K Buy
293
+274
+1,442% +$6.15K ﹤0.01% 2534
2025
Q4
$690 Buy
+19
New +$625 ﹤0.01% 3042

Other funds holding ZBIO

Larson Financial Group's ZBIO Position: Q3 2026 in Review

Larson Financial Group increased its Zenas BioPharma (ZBIO) stake by 20% in Q3 2026, buying an estimated $2.8K and bringing the position to 545 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

Larson Financial Group first reported a position in ZBIO in Q4 2025 and has held it in 4 quarters since. 153 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.

  • Larson Financial Group held 545 shares of Zenas BioPharma worth $14.7K as of Q3 2026.
  • Larson Financial Group bought 91 Zenas BioPharma shares in Q3 2026, an estimated $2.8K.
  • Zenas BioPharma made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2296 holding.
  • Larson Financial Group first reported a position in Zenas BioPharma in Q4 2025 and has held it in 4 quarters since.
  • 153 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.